Consensus Report
Peptides
Moderate Consensus
out of 5
Based on 28 videos (41 hours analyzed) across the experts · Updated 2026-06-29
Stance update (2025 – 2026): Two things happened at once. Demand exploded — a gray-market 'peptide gold rush' of research-only vials, telehealth, and influencer stacks (BPC-157 searches up sharply year-over-year). And regulators tightened: the FDA moved several popular peptides, including BPC-157 and CJC-1295, into 'Category 2,' effectively banning compounding pharmacies from producing them. The net effect is more people buying unproven peptides from less-regulated sources — exactly the situation the experts warn against.
Expert Positions
The Verdict
There is no single verdict on 'peptides' — the category is wildly heterogeneous. A handful are FDA-approved and genuinely evidence-backed (PT-141 for low libido, tesamorelin for visceral fat), while the most-hyped recovery peptides (BPC-157, TB-500) rest almost entirely on animal data. The one thing every expert who covers peptides agrees on: physician-prescribed, quality-sourced, lab-monitored use only — and get the fundamentals right first. Treat 'peptides' as a question to ask one molecule at a time, not a single yes/no.
Where They Disagree
Attia is the evidence-first skeptic — he calls most trendy peptides 'Frankenstein compounds' touted by influencers and notes he tried BPC-157 and felt nothing — while Hyman's platformed guests (Dr. Edwin Lee, Dr. Matt Cook) build whole clinical protocols around peptide stacks for healing, immunity, and longevity.
On mitochondrial peptides like SS-31 (elamipretide): mitochondrial biologist Dr. Martin Picard (via Huberman) notes clinical trials have largely failed to meet expectations, while Dr. Edwin Lee (via Hyman) presents them as cellular-energy optimizers.
+ 1 more disagreement in the full report
About This Analysis
This consensus report on Peptides is based on 28 videos (41 hours analyzed) from five longevity experts: Andrew Huberman, Peter Attia, Rhonda Patrick, Bryan Johnson, and Mark Hyman. Each expert's position was independently analyzed from their published video content, including lectures, podcast episodes, and Q&A sessions with 1,000+ guest scientists.
The full report includes 8 key findings, dosage and protocol details, expert deep dives with direct video citations and timestamps, risk considerations, and related supplement synergies.
Common Questions
Unlock the Full Report
Get dosages, timing protocols, expert deep dives with video citations, and risks for Peptides.
Every recommendation traces back to a specific expert, video, and timestamp.
$9/month or $79/year · Cancel anytime